Mengwei Yao
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
-
- DNA Repair Mechanisms 3
- RNA modifications and cancer 3
- Metabolism, Diabetes, and Cancer 2
- Genetics 10
- Mesenchymal stem cell research 10
- Co-authors
- Xiang Xu (14 shared papers)Luoquan Ao (8 shared papers)Wei Xing (7 shared papers)Xiaofeng Wu (5 shared papers)Wei Guo (4 shared papers)Xiang Ao (5 shared papers)Xueting Hu (4 shared papers)Zhan Li (5 shared papers)
- Journals
- Medicine (2 papers)Stem Cell Research & Therapy (2 papers)Journal of Clinical Laboratory Analysis (1 paper)Scientific Reports (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Mengwei Yao
23 papers receiving 639 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 232
- Genetics 88
- Molecular Biology 428
- Biotechnology 35
- Oncology 95
Countries citing papers authored by Mengwei Yao
This map shows the geographic impact of Mengwei Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengwei Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengwei Yao more than expected).
Fields of papers citing papers by Mengwei Yao
This network shows the impact of papers produced by Mengwei Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengwei Yao. The network helps show where Mengwei Yao may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengwei Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer Hit paper breakdown → | 2022 | 276 |
| 2 | 2020 | 89 | |
| 3 | 2020 | 62 | |
| 4 | 2018 | 43 | |
| 5 | 2018 | 21 | |
| 6 | 2022 | 20 | |
| 7 | 2022 | 18 | |
| 8 | 2017 | 18 | |
| 9 | 2024 | 14 | |
| 10 | 2023 | 12 | |
| 11 | 2018 | 11 | |
| 12 | 2016 | 10 | |
| 13 | 2019 | 8 | |
| 14 | 2019 | 8 | |
| 15 | 2023 | 6 | |
| 16 | 2017 | 6 | |
| 17 | 2017 | 5 | |
| 18 | 2019 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2021 | 3 |
About Mengwei Yao
Mengwei Yao is a scholar working on Molecular Biology, Genetics, Immunology, Cancer Research and Oncology, having authored 26 papers that have together received 645 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (10 papers), Cancer-related molecular mechanisms research (3 papers), DNA Repair Mechanisms (3 papers), RNA modifications and cancer (3 papers), Pancreatic function and diabetes (2 papers), MicroRNA in disease regulation (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Cancer Research (232 citations), Genetics (88 citations), Molecular Biology (428 citations), Biotechnology (35 citations) and Oncology (95 citations). Mengwei Yao has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiang Xu, Luoquan Ao, Wei Xing, Xiaofeng Wu, Wei Guo, Xiang Ao, Xueting Hu, Zhan Li, Weijun Wan and Yu Yang. Their work appears in journals such as Medicine, Stem Cell Research & Therapy, Journal of Clinical Laboratory Analysis, Scientific Reports and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.